ArticleClinical proteomics2023

Development of a predictive model to distinguish prostate cancer from benign prostatic hyperplasia by integrating serum glycoproteomics and clinical variables.

Caterina Gabriele et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.